Fresenius Medical Care AG & Co. KGaA
ISIN: DE0005785802 | Ticker: FME | LEI: 549300CP8NY40UP89Q40
Country: Germany
Fresenius Medical Care is the world's leading provider of products and services for individuals with renal diseases of which around 3.8 million patients worldwide regularly undergo dialysis treatment. Through its network of 4,171 dialysis clinics, Fresenius Medical Care provides dialysis treatments for approximately 345,000 patients around the globe. Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. Along with its core business, the Renal Care Continuum, the Company focuses on expanding in complementary areas and in the field of critical care. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and on the New York Stock Exchange (FMS).
Year founded1996
Served areaWorldwide
Headcount123,000
HeadquartersElse-Kröner-Straße 1, 61352 Bad Homburg v. d. Höhe – Germany
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 21.03.23 | Mazur-Hofsäß, Dr. Katarzyna | Board | Buy | EUR 11,199.36 |
| 21.03.23 | Mazur-Hofsäß, Dr. Katarzyna | Board | Buy | EUR 10,933.84 |
| 21.03.23 | Mazur-Hofsäß, Dr. Katarzyna | Board | Buy | EUR 9,608.67 |
| 21.03.23 | Mazur-Hofsäß, Dr. Katarzyna | Board | Buy | EUR 4,343.80 |
| 17.03.23 | Langheim, Thorsten | Board | Sell | EUR 48,125.00 |
| 17.03.23 | Bauerreis, Stefan | Board | Buy | EUR 23,440.00 |
| 17.03.23 | Langheim, Thorsten | Board | Sell | EUR 18,750.00 |
| 17.03.23 | Langheim, Thorsten | Board | Sell | EUR 16,000.00 |
| 17.03.23 | Langheim, Thorsten | Board | Sell | EUR 15,100.00 |
| 17.03.23 | Langheim, Thorsten | Board | Sell | EUR 14,250.00 |
DE0005785802
LEI549300CP8NY40UP89Q40
SectorHealth Care Equipment & Services
IndustryHealth Care Providers & Services
Sub-IndustryMDAX
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.